Skip to main content

Contraception for Women with a History of Solid Organ Transplantation

  • Chapter
  • First Online:
Contraception for the Medically Challenging Patient

Abstract

For women with uncomplicated solid organ transplantation, the US Medical Eligibility Criteria for Contraceptive Use consider all methods of contraception category 2 (benefits generally outweigh risks). Pregnancy is not recommended until graft function is stable, and thereafter should be carefully timed in conjunction with a transplant team. For this reason, it is recommended that patients with a history of transplantation use highly effective methods of contraception when not actively trying to conceive. The only types of contraception that have been systematically studied in women after transplantation are combined hormonal contraception and the intrauterine device (IUD). IUDs were historically thought to be contraindicated in a post-transplant population, but modern literature is overwhelmingly reassuring. These studies, though small series, are largely reassuring. Long-acting reversible contraception (LARC) methods are underutilized in this population.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    It should be noted that the mechanism of immunosuppression for solid organ transplantation is largely the TNF-alpha pathway, which is different than the protease pathway inhibited by HIV. However, the same concepts apply, namely that immunosuppression does not present a contraindication for most contraceptive use, including IUD. For a full discussion of HIV and contraception, please see Chap. 6.

References

  1. 2012 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1994–2003. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; University Renal Research and Education Association, Ann Arbor, MI.

    Google Scholar 

  2. 2011 Annual Data Report. http://srtr.transplant.hrsa.gov/annual_reports/2011/. Accessed 22 Dec 2013.

  3. Farber M. Pregnancy and renal transplantation. Clin Obstet Gynecol. 1978;21:931.

    Article  CAS  PubMed  Google Scholar 

  4. Mastrobattista JM, Gomez-Lobo V. Pregnancy after solid organ transplantation. Obstet Gynecol. 2008;112:919.

    Article  PubMed  Google Scholar 

  5. Coscia LA, Constantinescu S, Moritz MJ, Frank AM, Ramirez CB, Maley WR, et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clin Transpl. 2010:65–85.

    Google Scholar 

  6. Coffin CS, Shaheen AAM, Burak KW, Myers RP. Pregnancy outcomes among liver transplant recipients in the United States: a nationwide case–control analysis. Liver Transpl. 2010;16:56.

    Article  PubMed  Google Scholar 

  7. Deshpande NA, James NT, Kucirka LM, Boyarsky BJ, Garonzik-Wang JM, Montgomery RA, et al. Pregnancy outcomes in kidney transplant recipients: a systematic review and meta-analysis. Am J Transplant. 2011;11:2388.

    Article  CAS  PubMed  Google Scholar 

  8. Deshpande NA, James NT, Kucirka LM, Boyarsky BJ, Garonzik-Wang JM, Cameron AM, et al. Pregnancy outcomes of liver transplant recipients: a systematic review and meta-analysis. Liver Transpl. 2012;18(6):621–9.

    Article  PubMed  Google Scholar 

  9. Ghazizadeh S, Lessan-Pezeshki M, Khatami M, Mahdavi M, Razeghi E, Seifi S, et al. Unwanted pregnancy among kidney transplant recipients in Iran. Transplant Proc. 2005;37(7):3085–6.

    Article  CAS  PubMed  Google Scholar 

  10. Xu L, Yang Y, Shi JG, Wang H, Qiu F, Peng W, et al. Unwanted pregnancy among Chinese renal transplant recipients. Eur J Contracept Reprod Health Care. 2011;16(4):270–6.

    Article  PubMed  Google Scholar 

  11. Bahamondes MV, Hidalgo MM, Bahamondes L, Monteiro I. Ease of insertion and clinical performance of the levonorgestrel-releasing intrauterine system in nulligravidas. Contraception. 2011;84(5):e11–6.

    Article  CAS  PubMed  Google Scholar 

  12. Gill JS, Zalunardo N, Rose C, Tonelli M. The pregnancy rate and live birth rate in kidney transplant recipients. Am J Transplant. 2009;9:1541.

    Article  CAS  PubMed  Google Scholar 

  13. Curtis KM, Jamieson DJ, Peterson HB, Marchbanks PA. Adaptation of the World Health Organization’s medical eligibility criteria for contraceptive use for use in the United States. Contraception. 2010;82(1):3.

    Article  PubMed  Google Scholar 

  14. McKay DB, Josephson MA, Armenti VT, August P, Coscia LA, Davis CL, et al. Reproduction and transplantation: report on the AST consensus conference on reproductive issues and transplantation. Am J Transplant. 2005;5(7):1592–9.

    Article  PubMed  Google Scholar 

  15. Morrison CS, Sekadde-Kigondu C, Sinei SK, Weiner DH, Kwok C, Kokonya D. Is the intrauterine device appropriate contraception for HIV-1-infected women? BJOG. 2001;108:784.

    CAS  PubMed  Google Scholar 

  16. Stringer EM, Kaseba C, Levy J, Sinkala M, Goldenberg RL, Chi BH, et al. A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus. Am J Obstet Gynecol. 2007;197:144e1.

    Google Scholar 

  17. Hubacher D, Lara-Ricalde R, Taylor DJ, Guerra-Infante F, Guzmán-Rodríguez R. Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. N Engl J Med. 2001;345:561.

    Article  CAS  PubMed  Google Scholar 

  18. U.S. Selected Practice Recommendations for Contraceptive Use, 2013. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6205a1.htm. Accessed 22 Dec 2013.

  19. Grimes DA, Schulz KF. Antibiotic prophylaxis for intrauterine contraceptive device insertion. Cochrane Database Syst Rev. 2001;(2):CD001327. doi:10.1002/14651858.CD001327.

  20. Leticee N, Viard J-P, Yamgnane A, Karmochkine M, Benachi A. Contraceptive failure of etonogestrel implant in patients treated with antiretrovirals including efavirenz. Contraception. 2012;85(4):425–7.

    Article  CAS  PubMed  Google Scholar 

  21. Kaunitz AM, Grimes DA. Removing the black box warning for depot medroxyprogesterone acetate. Contraception. 2011;84:212.

    Article  PubMed  Google Scholar 

  22. Moe S, Drüeke T, Cunningham J, Goodman W, Martin K, Olgaard K, et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2006;69(11):1945–53.

    Article  CAS  PubMed  Google Scholar 

  23. Canalis E, Mazziotti G, Giustina A, Bilezikian JP. Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int. 2007;18n:1319–28.

    Article  Google Scholar 

  24. Pietrzak B, Kaminski P, Wielgos M, Bobrowska K, Durlik M. Combined oral contraception in women after renal transplantation. Neuro Endocrinol Lett. 2006;27:679.

    CAS  PubMed  Google Scholar 

  25. Pietrzak B, Bobrowska K, Jabiry-Zieniewicz Z, Kaminski P, Wielgos M, Pazik J. Oral and transdermal hormonal contraception in women after kidney transplantation. Transplant Proc. 2007;39:2759.

    Article  CAS  PubMed  Google Scholar 

  26. Jabiry-Zieniewicz Z, Bobrowska K, Kaminski P, Wielgos M, Zieniewicz K, Krawczyk M. Low-dose hormonal contraception after liver transplantation. Transplant Proc. 2007;39:1530.

    Article  CAS  PubMed  Google Scholar 

  27. Paternoster DM, Riboni F, Bertolino M, Garofalo G, Lazzarich E, Surico N, et al. The contraceptive vaginal ring in women with renal and liver transplantation: analysis of preliminary results. Transplant Proc. 2010;42:1162.

    Article  CAS  PubMed  Google Scholar 

  28. Azasan Prescribing Information (PI)—azasan-pi.pdf. http://cdn.salix.com/shared/pi/azasan-pi.pdf. Accessed 22 Dec 2013.

  29. CellCept. http://www.cellcept.com/cellcept/index-h.htm. Accessed 22 Dec 2013.

  30. Trussell J. Contraceptive Efficacy. In: Hatcher RA, Trussell J, Nelson AL, Cates W, Kowal D, Policar M, editors. Contraceptive technology. Revised 20th ed. New York, NY: Ardent Media; 2011.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Colleen M. Krajewski M.D., M.P.H. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Krajewski, C.M., Burke, A.E. (2014). Contraception for Women with a History of Solid Organ Transplantation. In: Allen, R., Cwiak, C. (eds) Contraception for the Medically Challenging Patient. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1233-9_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1233-9_9

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-1232-2

  • Online ISBN: 978-1-4939-1233-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics